A vaccination campaign is underway across England to provide free meningitis B (MenB) jabs to young people, with nearly 90,000 doses administered and 135,000 additional appointments scheduled for the coming weeks. The initiative follows a significant outbreak in Kent that resulted in 29 confirmed or suspected cases and two deaths.
The vaccine is available to 17 and 18-year-olds in sixth form and students under 25 entering residential universities or further education colleges for the first time this autumn. Approximately a million young people in England are expected to be eligible, including those born between September 1, 2007 and August 31, 2008, as well as international and out-of-region students planning to study in England. The vaccine requires two doses administered at least 28 days apart for optimal protection.
Eligible individuals can book appointments at high street pharmacies or through the NHS National Booking Service if already registered with a GP. Walk-in services are available for those born on or after July 21, 2001. Common side effects include localized swelling, redness, mild fever, nausea, headache or muscle aches, which typically resolve within one to two days. Serious adverse effects are rare.
MenB infection can cause serious complications including meningitis and sepsis, potentially resulting in life-altering disabilities such as amputations, hearing loss and brain damage. Research indicates first-year university students face approximately seven times higher infection risk compared to peers not attending university, attributed to increased social contact and shared living arrangements. While the MenB vaccine does not prevent person-to-person transmission and does not protect against all B bacteria strains, health experts recommend vaccination to prevent severe illness.
The MenB vaccine was introduced to the NHS childhood immunisation programme for babies born on or after July 1, 2015, but teenagers and young adults over 11 have not routinely received it. UK vaccine experts are recommending government consideration of routine MenB vaccination for all teenagers around age 15, with individual nations responsible for determining implementation policy.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI